Document Preview Unavailable

Post‐hoc analysis of the tofogliflozin post‐marketing surveillance study (J‐STEP/LT): Tofogliflozin improves liver function in type 2 diabetes patients regardless of BMI

Uchinuma, Hiroyuki; Matsushita, Mitsunori; Tanahashi, Masaya; Suganami, Hideki; Utsunomiya, Kazunori; et al.  Journal of Diabetes Investigation Vol. 16, Iss. 4,  (Apr 1, 2025): 615-628.

You might have access to this document